Back to VIR

GOLDMAN SACHS GROUP INC → VIR

GOLDMAN SACHS GROUP INC VIR Position History

Vir Biotechnology, Inc. • Healthcare

Quarters held
15
Latest value
$124K
Q3 2026
Peak value
$28M
First seen
Q2 2025

Dollar value over time

Show data table
PeriodPosition value
Q2 2025$6.2M
Q2 2025$280K
Q3 2025$8.4M
Q3 2025$299K
Q4 2025$437K
Q4 2025$9M
Q4 2025$9M
Q4 2025$437K
Q1 2026$28M
Q1 2026$1.1M
Q2 2026$22.2M
Q2 2026$1.9M
Q3 2026$2M
Q3 2026$7.3M
Q3 2026$124K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$124K11.1K——
Q3 2026$7.3M654.9K——
Q3 2026$2M180.6K——
Q2 2026$1.9M186.0K——
Q2 2026$22.2M2.18M——
Q1 2026$1.1M126.6K——
Q1 2026$28M3.12M——
Q4 2025$437K72.5K——
Q4 2025$9M1.50M——
Q4 2025$9M1.50M——
Q4 2025$437K72.5K——
Q3 2025$299K52.4K——
Q3 2025$8.4M1.47M——
Q2 2025$280K55.5K——
Q2 2025$6.2M1.23M——

Other funds holding VIR

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B